The global burden of tuberculosis mortality in children: a mathematical modelling study

Peter J Dodd1, Courtney M Yuen2, Charalambos Sismanidis3

  • 1School of Health and Related Research, University of Sheffield, Sheffield, UK.

Insights

Tuberculosis caused nearly 239,000 deaths in children globally in 2015, with most occurring in those under 5 and not receiving treatment. This highlights a critical gap in child mortality data and a significant opportunity for intervention.

Area of Science:

  • Global Health
  • Epidemiology
  • Pediatric Infectious Diseases

Background:

  • Tuberculosis (TB) is a significant global health issue, with millions of cases annually.
  • Paediatric TB represents a substantial portion of the global TB burden, yet mortality data is lacking.
  • Children, especially younger ones, are highly vulnerable to severe TB and associated mortality.

Purpose of the Study:

  • To estimate the global mortality burden of TB in children younger than 15 years.
  • To provide age-disaggregated mortality estimates for paediatric TB, addressing a gap in official child mortality statistics.
  • To utilize a novel approach independent of vital registration data for comprehensive mortality assessment.

Main Methods:

  • A mathematical modelling study was conducted for 217 countries and territories.
  • A case-fatality-based approach was employed, integrating paediatric TB notification data, HIV, and antiretroviral treatment (ART) data.
  • Systematic review evidence on case-fatality ratios was applied to WHO paediatric TB incidence estimates, disaggregated by age, HIV, and treatment status.

Main Results:

  • An estimated 239,000 (95% UI 194,000–298,000) deaths from TB occurred in children under 15 globally in 2015.
  • Eighty percent of these deaths (191,000) were in children younger than 5 years.
  • Over 96% of all paediatric TB deaths occurred in children not receiving TB treatment, with significant burdens in Southeast Asia and Africa, and a notable proportion in children with HIV.

Conclusions:

  • Tuberculosis is a leading cause of death in children globally and has been overlooked in child mortality analyses.
  • The vast majority of paediatric TB deaths occur in children not receiving treatment, indicating substantial potential for mortality reduction.
  • Addressing paediatric TB, particularly among vulnerable populations and those with HIV, is crucial for reducing child mortality worldwide.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Probability Laws01:49

Probability Laws

Overview
44.6K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
560
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
669
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K